Similar Papers

Paper Title
Journal
Date
Author
Ceftazidime plus teicoplanin versus ceftazidime plus amikacin as empiric therapy for fever in cancer patients with granulocytopenia
F Meunier ... M Aoun And
British Journal of Haematology | VOL. 76
F Meunier, et. al.F Meunier ... M Aoun And
01 Dec 1990
Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients.
P Eggimann ... M P Glauser
The Journal of antimicrobial chemotherapy | VOL. Suppl 32 b
P Eggimann, et. al.P Eggimann ... M P Glauser
01 Nov 1993
Fever in cancer patients as a cause of attendance in emergency room
M Vidal ... A Ferrer
Journal of Clinical Oncology | VOL. 27
M Vidal, et. al.M Vidal ... A Ferrer
20 May 2009
Inpatient Burden, Characteristics and Outcomes Associated with Venous Thrombotic Complications Among Patients with Paroxysmal Nocturnal Hemoglobinuria
Udhayvir Singh Grewal ... Usha Perepu
Blood | VOL. 140
Udhayvir Singh Grewal, et. al.Udhayvir Singh Grewal ... Usha Perepu
15 Nov 2022
View more papers

More From: Blood

Paper Title
Journal
Date
Author
How I approach pharmacological thromboprophylaxis in children.
Anthony A Sochet ... Neil A Goldenberg
Blood | VOL. -
Anthony A Sochet, et. al.Anthony A Sochet ... Neil A Goldenberg
03 Feb 2025
Woyach JA, Burbano GP, Ruppert AS, etal. Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL. Blood. 2024;143(16):1616-1627.
-
Blood | VOL. 145
--
30 Jan 2025
A novel therapy with a rational design for AML.
Maria L Amaya
Blood | VOL. 145
Maria L AmayaMaria L Amaya
30 Jan 2025
For how long has this problem been there?
Niccolò Bolli ... Matteo Claudio Da Vià
Blood | VOL. 145
Niccolò Bolli, et. al.Niccolò Bolli ... Matteo Claudio Da Vià
30 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.